RCT | Precuneus magnetic stimulation for Alzheimer’s disease.
8 Nov, 2022 | 12:12h | UTCPrecuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial – Brain
Commentary: Novel Approach to TMS May Slow Cognitive Decline in Alzheimer’s – Medscape (free registration required)
Commentary on Twitter
In a randomized, double-blind, phase II trial, Koch et al. find that 24 weeks of repetitive transcranial magnetic stimulation of the precuneus slows down cognitive and functional decline in patients with Alzheimer’s disease. https://t.co/jODfVG3GAJ pic.twitter.com/p9ncGTfS7J
— Brain (@Brain1878) October 27, 2022